• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Venture Capital Matters

#VentureCapital: VC meets social media

  • Pitch a Startup
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Neural Analytics, Inc. Raises $22 Million in Series C Financing

May 8, 2019 By 3v.org Leave a Comment

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced today that it has raised approximately $22 million from sale of Series C shares led by Alpha Edison and the Company has also issued warrants to purchase stock in connection to the financing. The investment brings Neural Analytics’ total funding to approximately $66 million.

“Over the past six years we have worked very hard to develop and validate new technologies into impactful products. Though the culmination of years of our work into U.S. FDA clearance & European CE mark was a meaningful milestone in 2018, it was only the start of our journey. With this financing Neural Analytics will be able to launch the Lucid Robotic System into clinical environments where it will have the greatest impact on patient outcomes,” said Leo Petrossian, Ph.D., Co-Founder and Chief Executive Officer of Neural Analytics.

The Lucid Robotic System is a cutting-edge technology that combines the Lucid™ M1 Transcranial Doppler (TCD) System with the NeuralBot™ System. It is an autonomous all-in-one robotic neurovascular ultrasound device designed to non-invasively search, measure and display objective brain blood flow information in real-time.

The Lucid Robotic System goes beyond supporting initial neurological assessment. It can be utilized throughout the patient care chain: from the use of a bubble study in the identification of right-to-left shunts, to monitoring for cerebral blood flow velocities in real time, to emboli monitoring. The Lucid Robotic System is currently active at select centers around the United States and Neural Analytics will continue to expand its commercialization.

“We are honored to deepen our partnership with Neural Analytics. Over the past year, the company has gained both FDA and EU CE Mark clearance for their revolutionary platform, which harnesses machine learning and robotics to accurately and quickly identify critical neurological conditions. We are confident that the company will play a central role in shaping the future of data driven diagnostics and bringing new technologies to healthcare professionals to better care for their patients,” said Nick Grouf, Managing Partner at Alpha Edison.

This announcement follows Neural Analytics’ recent enrollment of their first patients into the CODEX Study, a prospective, single-arm, global multi-center study using an investigational iteration of the Lucid Robotic System, that aims to further explore the technical feasibility of this technology in a wider range of patients and neurological pathologies where monitoring of brain blood flow data would be of benefit in the assessment of neurological diseases.

Neurological diseases such as stroke affects more than 795,000 people each year in the U.S.1 Nearly 200,000 of these strokes are considered to be cryptogenic, or of unknown mechanism.2 Patent Foramen Ovale (PFO), a form of right-to-left shunt affecting 1 in 4 people, is known as a risk factor for ischemic stroke and is commonly screened in patients with cryptogenic stroke.3 Incorrect assessment of stroke leads to misdiagnosis and treatment delays, resulting in death or disability for patients.

About Alpha Edison

Alpha Edison is an early stage venture firm that partners with courageous entrepreneurs to build industry-changing technology platforms. We share our research and expertise in business model innovation to help ambitious founders create new markets, unlock latent demand, and scale businesses that change our world – for the better. Based in Los Angeles, CA, you can learn more about us at www.alphaedison.com.

About Neural Analytics, Inc.

Neural Analytics, Inc. is a medical robotics company developing and commercializing technologies to measure and track brain health. The company’s Lucid Robotic System (Lucid™ M1 Transcranial Doppler Ultrasound System and NeuralBot™ System) is a robotically assisted ultrasound system for brain health assessment. It combines an all-in-one neurovascular ultrasound device, designed to non-invasively measure and display brain blood flow information under the guidance of a healthcare professional. The company’s technology integrates ultrasound, robotics and machine learning to empower neurologists with critical information about brain health to make clinical decisions and improve patient outcomes.

More information is available at http://www.neuralanalytics.com.

Center for Disease Control. Stroke Facts. https://www.cdc.gov/stroke/facts.htm. Accessed April 25, 2018
Mozzafarian D, et al. Circulation. 2015;131:e29-e322
McDermott, LM Amer Coll Cardiol.2018. European Position Paper on Management of PFO.

Related

Filed Under: PR

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • FreshCut Secures $15M Funding to Accelerate Transformation of Web3 Gaming Content Ecosystem
  • Thought Machine Raises $160m in Series D Funding Round – Doubling Valuation to $2.7bn and Accelerating Plans to Bring World’s Banks Onto Cloud Technology
  • Foundational Skills Checklist
  • LucidLink Raises $20 Million in Series B to Solve Remote Collaboration Challenges for Global Creative Teams
  • Storyblok Raises $47M Series B Led by Mubadala Capital and HV Capital to Make Headless Content Management the New Standard
  • A bridge between Web2 and Web3
  • Fresh Technology Inc. Closes $7 Million Series A to Drive Innovation in Modern Restaurant Kitchens
  • SoftBank will be cutting its startup investments by 50-75% through March 2023
  • Paddle, which provides a billing backend for SaaS companies, raises a $200M Series D
  • RGo Robotics Exits Stealth Mode with $20M in Funding & Major Customer Wins

Media Partners

  • VPNW
  • S3H
  • OPINT
  • Press Media Release
  • OSINT
  • Digital Market
  • Briefly

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Opinion
  • Venture Capital

Copyright © 2018 3V.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT